[Justice Prabha Sridevan] Today the judicial authority may be faced with balancing patent rights and patients’ rights or right to life. It shall use all the tools at its command and innovate if necessary, but shall rule in favour of life.
Read MoreEarlier today 27 (update 16-09-2020: 30) civil society organisations sent a joint letter to Commissioner Breton summarising our responses to the Article 17 guidance consultation that closed last week… The letter expresses concerns that the proposed Article 17 guidance endorses the use of automated content blocking by online services even though it is clear that this will lead to the violation of fundamental rights. It also warns that implementations of Article 17 based on the proposed guidance will violate established principles of EU law.
Read MoreFor all those interested who were waiting for the development of the Global Congress in 2020, we inform you that the event and in its full version, has been postponed to the year 2021. However, we invite you to participate in the activities that we will be organizing for this 2020 to be realized between the 5th and the 9th of October 2020, in order to have a virtual meeting space for the discussion of these topics that have shown their relevance in the framework of the global pandemic.
Read More[Paul Keller] At the end of July the Commission published a long awaited “targeted consultation addressed to the participants to the stakeholder dialogue on Article 17 of the CDSM Directive“. With this consultation the Commission makes good on its (pre-covid) promise to “share initial views on the content of the Article 17 guidance” with the participants of the stakeholder dialogue. Nestled in-between 18 questions, the consultation document provides a detailed outline of what the Commission’s guidance could look like once it is finalised. While we have been rather sceptical after the end of the six meetings of the stakeholder dialogue meetings, we are pleased to see that the initial views shared by the Commission express a genuine attempt to find a balance between the protection of user rights and the interests of creators and other rightholders, which reflects the complex balance of the provisions introduced by Article 17 after a long legislative fight.
Read More[Diane Peters and Eric Steuer] We’re pleased to announce today that Creative Commons is taking on leadership and stewardship of the Open COVID Pledge. Earlier this year, CC joined forces with an international group of researchers, scientists, academics, and lawyers seeking to accelerate the development of diagnostics, vaccines, therapeutics, medical equipment, and software solutions that might be used to assist in the fight against COVID-19. The result was the Open COVID Pledge, a project that offers a simple way for universities, companies, and others to make their patents and copyrights available to the public to be utilized in the current public health crisis. Users of Creative Commons licenses will be familiar with the Open COVID Pledge’s approach. Like CC licenses, the Open COVID Pledge offers free, standard, public licenses that anyone can use to remove unnecessary obstacles to the dissemination of knowledge.
Read More[Cory Doctorow] Five years ago, South Africa embarked upon a long-overdue overhaul of its copyright system, and, as part of that process, the country incorporated some of the best elements of both U.S. and European copyright. From the U.S.A., South Africa imported the flexible idea of fair use — a set of tests for when it’s okay to use others’ copyrighted work without permission. From the E.U., South Africa imported the idea of specific, enumerated exemptions for libraries, galleries, archives, museums, and researchers. Both systems are important for preserving core human rights, including free expression, privacy, education, and access to knowledge; as well as important cultural and economic priorities such as the ability to build U.S.- and European-style industries that rely on flexibilities in copyright.
Read MoreAuthor: Bernd Justin Jütte Abstract: The Directive on Copyright in the Digital Single Market supplements the existing exception for teaching of the Information Society Directive. The new exception focuses on digital and...
Read More[EIFL] The Copyright Amendment Bill [B13B – 2017] had been sitting on the desk of President Cyril Ramaphosa for over a year waiting to be signed into law. In June 2020, when Blind South Africa issued a legal challenge over the delay, the President acted. But instead of signing the Bill that had been approved by the legislature, the President used his prerogative to return it to parliament citing constitutional concerns with certain aspects, including new exceptions for libraries, education and persons with disabilities. The President’s rejection of the Bill is widely seen as the result of pressure by copyright industries, and the threat of trade sanctions and reduced future investment from the United States and the European Union.
Read More[Teresa Hackett] In Part II of this two-part blog, EIFL Copyright and Libraries Programme Manager Teresa Hackett examines how the COVID-19 pandemic has highlighted the importance of the right to research through two key issues, text and data mining and digital preservation by cultural heritage institutions, and how WIPO’s proven formula could address the issues. In Part 1 of the blog, we looked at the immediate challenges the COVID-19 pandemic posed for the copyright and licensing framework as education moved online.
Read More[Nirmalya Syam] A regular session of the TRIPS (Agreement on Trade-Related Aspects of Intellectual Property Rights) Council was held virtually on 30 July 2020. This session offered the first opportunity for the World Trade Organization (WTO) Members to discuss intellectual property (IP) related issues in the context of COVID-19. Discussions focused on national measures taken by various countries in relation to IP in response to COVID-19 as well as the scope of the use of TRIPS flexibilities across the spectrum of various IP rights in order to ensure rapid development, scaled up manufacturing of and affordable, timely and equitable access to various technologies and products required to respond to COVID-19. South Africa made a strong general statement pointing to the need to consider new bold measures that will comprehensively and expeditiously address IP challenges.
Read More[World Intellectual Property Organization press release] On 29 July, the Directors-General of the World Health Organization (WHO), the World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO) presented a new edition of the Trilateral Study on Access to Medical Technologies and Innovation. Building on the first edition launched in 2013, the publication seeks to strengthen the understanding of the interplay between the distinct policy domains of health, trade and intellectual property (IP), and how they affect innovation and access to medical technologies, such as medicines, vaccines and medical devices. The second edition provides an improved, evidence-based foundation for policy debate and informed decision-making at a critical time for global health.
Read More[Electronic Information for Libraries] EIFL welcomed the opportunity to submit comments on Brazil’s implementation of the Marrakesh Treaty for persons with print disabilities. The comments focused on Article 4(4) of the treaty, an optional provision that allows a country to confine exceptions to works that are not available on the commercial market under reasonable terms, the so-called ‘commercial availability test’. EIFL opposes the introduction of a commercial availability test because it would undermine the overarching objective of the Marrakesh Treaty, which is to expand the availability of accessible format works for persons with print disabilities. It would especially hamper cross-border exchange of accessible format works, widely recognized as key to ending the global ‘book famine’ for persons with print disabilities, and fundamental to the treaty’s success.
Read More[Francisco Colman Sercovich] …The markets of the poorest countries, those most affected by prior pandemics thus far, are not profitable enough for wealthy countries-based multinationals to justify engaging in vaccine R&D. Beyond health-related imperatives, the large subsidies being swiftly granted by wealthy countries now in order to not just shorten schedules but also, perhaps for the most part, to ensure domestic production capacity and control of intellectual property rights, are a glaring recognition of the market failures involved and the ensuing need for public intervention — albeit often tinted by a narrow-minded nationalism.
Read More[International Federation of Library Associations] There has been disappointing news from Mexico, where recent copyright legislation risks making access to information significantly harder, while also undermining the role of the judiciary and lawmakers. Local libraries and other actors are calling for a constitutional review.
Read More[Natalia Mileszyk] Last month, we held the first edition of our Copyright Directive Webinars, aimed at explaining the different provisions of the new Copyright Directive and making suggestions on what to advocate for during the implementation process of those provisions at a national level, to expand and strengthen user rights. We’ve now released the presentations and video recordings of the webinars. As you know, many countries are now speeding up with the process of implementation of the Directive – you can find below a short summary of what’s going on.
Read MoreUNESCO has launched a two-year consultation process to build a global consensus on open science. The consultation process includes the establishment of an Open Science Advisory Committee appointed by the Director-General of UNESCO that will be in charged of drafting the UNESCO Recommendation on Open Science so that we can have a “regionally balanced, inclusive and transparent consultation. Carolina Botero, Director of Fundacion Karisma and Host of the next Global Congress on IP and the Public Interest has been named to the Open Science Advisory Committee.
Read More[Carlos Correa] As often said, major crises bring about challenges but also opportunities. The strategic importance of a local pharmaceutical industry has been growingly recognized as a result of the COVID-19 crisis. Developing countries should take advantage of this opportunity to strengthen their pharmaceutical industry, including biological medicines. Industrial policies would need to be reformulated under an integrated approach so as to expand value added & create jobs while addressing public health needs. South-South cooperation may also play an important role in increasing the contribution of developing countries to the global production of pharmaceuticals.
Read More[Mehtab Khan] The pandemic has put several pressures on the scope of fair use. Within a matter of weeks, millions of people lost physical access that they normally would have had through libraries and cultural institutions. Fair use was built to be flexible for circumstances like these. But now that users have changed the way that they are accessing copyrighted works, primarily through intermediaries, this has implicated copyright and fair use in novel ways.
Read More[Teresa Hackett] At the end of March, at the height of the global lockdown, UNESCO estimates that more than 1.5 billion learners in 193 countries were affected by country-wide or localized closures of schools and other educational institutions. The closures happened overnight and mid-way through the academic year, leaving no time for teachers and students to prepare. For education to continue, it had to move off-campus and online.
Read More[Nirmalya Syam] Abstract: The rising incidence of COVID-19 will require all countries, particularly developing and least developed countries, to be able to procure and manufacture the products required for the diagnosis, prevention and treatment of COVID-19. Intellectual property (IP) rights over such products can constrain the ability of countries to rapidly procure and produce and supply the products required at a mass scale. This Policy Brief describes the measures and actions taken by different countries to address potential IP barriers to access to the products required for COVID-19.
Read More
Comments on: Civil Society Documents Comments on: industry | infojustice